Levomoprolol-d7

CAS: 77164-20-6

Ref. 3D-CDA16420

Produktinformation

• Name: Levomoprolol-d7
• Synonyme: (-)-(S)-1-(Isopropylamino)-3-(o-methoxyphenoxy)-2-propanol, (-)-Moprolol, (2S)-1-(2-Methoxyphenoxy)-3-[(1-methylethyl)amino]-2-propanol, (2S)-1-(2-methoxyphenoxy)-3-[(1-methylethyl)amino]propan-2-ol, (S)-1-(2-Methoxyphenoxy)-3-((1-methylethyl)amino)-2-propanol, (S)-1-(Isopropylamino)-3-(2-methoxyphenoxy)propan-2-ol, 2-Propanol, 1-(2-methoxyphenoxy)-3-((1-methylethyl)amino)-, (S)-, 2-Propanol, 1-(2-methoxyphenoxy)-3-[(1-methylethyl)amino]-, (2S)-, Levomoprolol [INN], Levomoprololum, Levomoprololum [Latin], Levotensin, Moprolol l-form, Unii-K4Non6Fson, l-Moprolol

Beschreibung

Levomoprolol-d7 is a levorotatory (left-handed) stereoisomer of levopropanolol, which is an antihypertensive drug. Levopropanolol acts on the heart muscle by decreasing the activity of beta-adrenergic receptors and increasing the activity of alpha receptors, leading to a decrease in heart rate and blood pressure. The compound was synthesized by asymmetric synthesis, making it a novel analog of levopropanolol. This particular stereoisomer has been associated with bowel disease and inflammatory bowel disease.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 239.31 g/mol
• Formel: C₁₃H₂₁NO₃
• Reinheit: Min. 95%